Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04600271
Other study ID # 2019/747
Secondary ID
Status Completed
Phase
First received
Last updated
Start date June 1, 2019
Est. completion date February 1, 2021

Study information

Verified date September 2021
Source Istanbul University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The study is planned to be a single-center study and includes patients who underwent major surgery within Istanbul University Istanbul Faculty of Medicine with an invasive arterial line. Our aim to define the incidence of acute renal injury in our setting and to investigate the risk factors listed in detailed description. After obtaining written informed consent from the patients, preoperative risk factors will be notes. Following standard anesthesia monitoring as well as routine anesthesia induction and maintenance, invasive arterial monitoring will be performed due to the major surgery and hemodynamic values will be recorded throughout the surgery. The primary outcome will be acute renal injury based on KDIGO's (Kidney Disease: Improving Global Outcomes) definition of acute renal damage. Postoperative data regarding this outcome as well as additional data listed in detailed description will be collected.


Description:

The study is a single-center study that observes patients who undergo major abdominal surgery within Istanbul University Istanbul Faculty of Medicine. Standard anesthesia monitoring (NIBP, SPO2(oxygen saturation by pulse oximetry), ECG) will be applied to the patients taken to the operation room. Routine anesthesia induction and maintenance will be performed by the anesthetist responsible for the patients. After anesthesia induction, invasive arterial monitoring will be performed. Our data collection and recording will be as follows: preoperative, intraoperative, postoperative. In the preoperative section; - Age, gender, height, weight, BMI of the patient - ASA (American Society of Anesthesiologists) classification, additional diseases and functional capacity - Drugs used (ACE-İ, ARB (angiotensin receptor blocker), Statin, B-blocker, NSAID) - Entry creatinine and eGFR (estimated glomerular filtration rate) calculated with CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) - Entry hemoglobin, lymphocyte, CRP (C reactive protein) - The presence of ascites in the abdomen In the intraoperative section; - Surgery (gynecological oncology surgery, gastrointestinal surgery, genitourinary surgery) and its duration - Applied form of anesthesia (general-regional) - Liquids given during the operation (Crystalloid (isotonic, isolyte, lactated ringer), colloid, albumin) and their amounts oNoradrenaline requirement - Use of diuretic, NSAID - Blood transfusion - Total amount of bleeding during the operation - First arterial blood gas electrolytes taken due to routine major surgery - The lowest amount of hemoglobin seen during the operation - Routine invasive artery monitorization due to major surgery, and mean arterial pressure In the postoperative section; - Requirement of intensive care - Blood transfusion requirement - Noradrenaline requirement - Use of diuretic and NSAID - Electrolyte values in the first blood gas taken routinely - Creatinine value immediately after the surgery and at 24th and 48th hours - First 48-hour urine output The diagnosis of acute renal injury is based on KDIGO's definition of acute renal damage. By analyzing from this information, significant risk factors for acute renal damage are identified and measures are taken against them.


Recruitment information / eligibility

Status Completed
Enrollment 425
Est. completion date February 1, 2021
Est. primary completion date November 1, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Age of =18 years - Patients who are ASA I-III - Patients who have undergone major noncardiac surgery - Patients who need post-operative intensive care follow-up due to major surgery or long surgery - Patients diagnosed with CKD but do not need routine hemodialysis Exclusion Criteria: - Age of <18 years - Patients who have undergone minor surgery - Surgeries which lasts <30 minutes - Patients who will be hospitalized less than two days postoperatively - Patients who need routine hemodialysis due to CKD - Patients who had renal transplantation

Study Design


Intervention

Drug:
Crystalloid Solutions
exposure
Colloid Blood Volume Expanders
exposure
Other:
blood replacement
exposure
Drug:
Diuretic
exposure
noradrenaline
exposure
Non-Steroidal Anti-Inflammatory Analgesics
exposure

Locations

Country Name City State
Turkey Istanbul University Istanbul Faculty of Medicine Departmant of Anesthesiology and Reanimation Istanbul

Sponsors (1)

Lead Sponsor Collaborator
Istanbul University

Country where clinical trial is conducted

Turkey, 

References & Publications (3)

Goren O, Matot I. Perioperative acute kidney injury. Br J Anaesth. 2015 Dec;115 Suppl 2:ii3-14. doi: 10.1093/bja/aev380. Review. — View Citation

Hobson C, Ruchi R, Bihorac A. Perioperative Acute Kidney Injury: Risk Factors and Predictive Strategies. Crit Care Clin. 2017 Apr;33(2):379-396. doi: 10.1016/j.ccc.2016.12.008. Review. — View Citation

Sun LY, Wijeysundera DN, Tait GA, Beattie WS. Association of intraoperative hypotension with acute kidney injury after elective noncardiac surgery. Anesthesiology. 2015 Sep;123(3):515-23. doi: 10.1097/ALN.0000000000000765. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Acute renal injury Acute renal injury description will be made with KDIGO criteria. 48 hours
Secondary Hospital stay Will be noted as days. 30-90 days
Secondary ICU stay Will be noted as days. 30-90 days
Secondary Chronic Kidney Disease will be noted after postoperative period. up to 1 year
Secondary Mortality will be noted in the hospital period. 30-90 days
Secondary Complication after surgery will be noted in the hospital period. 30-90 days
See also
  Status Clinical Trial Phase
Completed NCT01920542 - Dexmedetomidine on Pediatric Heart Operation N/A
Recruiting NCT04334707 - Kidney Precision Medicine Project
Completed NCT02765464 - Acute Kidney Injury in Critically Ill Patients
Recruiting NCT05970952 - Acute Kidney Injury in Intensive Care Patients
Recruiting NCT05145283 - Recombinant Human C1 Esterase Inhibitor (Conestat Alfa) in the Prevention of Acute Ischemic Cerebral and Renal Events After Transcatheter Aortic Valve Implantation Phase 2
Active, not recruiting NCT05384899 - Kidney Precision Medicine Project (KPMP) - COVID-19 Protocol
Completed NCT02838667 - Prevention and Early Detection and Intervention of Post-Coronary Artery Bypass Grafting Surgery (CABG) Acute Kidney Injury (AKI) N/A
Not yet recruiting NCT05666232 - Renal and Cardiac Risk Factors of AKI After Liver Transplantation
Completed NCT02974946 - Kidney Protection Using the RenalGuard® System in Cardiac Surgery N/A
Recruiting NCT05186636 - Dialyzing Wisely - Improving the Delivery of Acute Renal Replacement Therapy to Albertans
Completed NCT01807195 - Acute Renal Injury Associated Contrast in Intensive Care Unit Patients N/A
Not yet recruiting NCT05308810 - Postoperative Kidney Functions in Geriatric Major Gynecologic-Oncologic Surgery
Recruiting NCT02743156 - Minimizing Contrast Utilization With IVUS Guidance in Coronary Angioplasty to Avoid Acute Nephropathy Phase 4
Recruiting NCT02417896 - Short Term Spironolactone for Prevention of Acute Kidney Injury After Cardiac Surgery N/A